A new dossier has been released for the product Lactium, according to its exclusive international distributor Pharmachem Laboratories (Pharmachem; Kearny, NJ).
A new dossier has been released for the product Lactium, according to its exclusive international distributor Pharmachem Laboratories (Pharmachem; Kearny, NJ). Lactium is a milk casein hydrolysate that has been studied for its relaxing properties.
"The dossier contains all the available research and application studies on Lactium, and is the most comprehensive technical document developed for the ingredient to date," said Mitch Skop, director of new product development for Pharmachem.
Lactium works by regulating stress symptoms in the digestive and cardiovascular systems. It has achieved Generally Recognized As Safe (GRAS) status and clinical trials have shown that its use comes without side effects. Lactium can be applied to the human diet as a supplement and a functional food ingredient.
The full dossier can be viewed at www.lactiumusa.com.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.